Buffington Mohr McNeal’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Buffington Mohr McNeal's LLY Position: Q1 2025 in Review
Buffington Mohr McNeal reduced its Eli Lilly (LLY) stake by 78% in Q1 2025, selling an estimated $1.74M and leaving 602 shares worth $497K. The position accounts for 0.1% of the portfolio, ranked #72.
Buffington Mohr McNeal first reported a position in LLY in Q2 2017 and has held it in 32 quarters since. The position peaked at $2.55M in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- Buffington Mohr McNeal held 602 shares of Eli Lilly worth $497K as of Q1 2025.
- Buffington Mohr McNeal sold 2,087 Eli Lilly shares in Q1 2025, an estimated $1.74M.
- Eli Lilly made up 0.1% of Buffington Mohr McNeal's portfolio in Q1 2025, its #72 holding.
- Buffington Mohr McNeal first reported a position in Eli Lilly in Q2 2017 and has held it in 32 quarters since.
- Buffington Mohr McNeal's Eli Lilly position peaked at $2.55M in Q2 2024.
- 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on Buffington Mohr McNeal's 13F filing for Q1 2025, filed 28 Apr 2025.